FDA Determines Regulatory Review Period for Cerenia Tablets Patent Extension

Summary

The US Food and Drug Administration (FDA) has officially confirmed the regulatory review period for Cerenia Tablets, a prescription medication, in order to extend the patent protection for the animal drug product, following a submission to the US Department of Commerce.